| Name | Title | Contact Details |
|---|
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
Laboratorie Dentachrome is a Quebec, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Smiths Medical is a leading global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the hospital, emergency, home and specialist environments. Our products are used during critical and intensive care, surgery, post-operative care during recovery, and in a series of home infusion therapies. We offer a number of some of the most respected and easily recognizable brands in the specialty device space: Portex™, Medex™, Deltec™, Level1™, Pneupac™, Wallace™, CADD™, BCI™, Jelco™, Medfusion™ and Surgivet™. Smiths Medical employs some 7,500 people, with manufacturing concentrated in the US, the UK, Mexico and Italy. Most territories are serviced through wholly-owned local sales and distribution companies. Smiths Medical is part of Smiths Group, a world leader in the practical application of technologies, delivering products and services for the threat & contraband detection, medical device, energy and communications markets worldwide. Smiths Group employs over 23,000 people in more than 50 countries.
Shamrock Marketing De, Inc. is a Chino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Oncologix is a diversified medical device and healthcare holding company. For its customers, Oncologix provides FDA approved medical devices and state licensed healthcare services. For its shareholders, Oncologix acquires profitable operations that build, maintain and nourish shareholder value. The Company`s corporate mission is to be the best small cap medical device and healthcare holding company in North America.